The every-5-days schedule is intentional and reflects how AMPK pathway activation works
Rotllan, N., Canyelles, M., Mauricio, D., Carles, J., & Julve, J
The safety profile of cagrilintide-semaglutide was broadly consistent with that reported for other incretin-based therapies, although gastrointestinal adverse events and treatment discontinuations occurred more frequently than with either semaglutide or cagrilintide alone, highlighting the importance of careful patient selection and long-term adherence
6.13.23 Christine said: This is a powder, which you dont need to worry about and therefore I do not review
En personas con sobrepeso, obesidad o metabolismo lento, los estudios muestran que puede apoyar modestamente la reduccin de masa grasa corporal